Affordable Access

deepdyve-link
Publisher Website

Long-term follow-up of bioprosthetic aortic valve replacement in patients aged ≤60 years.

Authors
  • Anselmi, Amedeo1
  • Flecher, Erwan2
  • Chabanne, Celine2
  • Ruggieri, Vito Giovanni2
  • Langanay, Thierry2
  • Corbineau, Hervé2
  • Leguerrier, Alain2
  • Verhoye, Jean-Philippe2
  • 1 Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital, Rennes, France. Electronic address: [email protected] , (France)
  • 2 Division of Thoracic and Cardiovascular Surgery, Pontchaillou University Hospital, Rennes, France. , (France)
Type
Published Article
Journal
The Journal of thoracic and cardiovascular surgery
Publication Date
Nov 01, 2017
Volume
154
Issue
5
Identifiers
DOI: 10.1016/j.jtcvs.2017.05.103
PMID: 28688707
Source
Medline
Keywords
License
Unknown

Abstract

The lifetime risk of SVD is considerable in patients aged ≤60 years at the time of bioprosthesis implantation. Nonetheless, durability remains consistent during the first decade; additional data are required for the second decade. Patients' information is pivotal for valve choice (competing-risks method).

Report this publication

Statistics

Seen <100 times